Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
Go back to Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting| DYNEGY, Inc. (NASDAQ: DYN) | Delayed: 17.11 -0.95 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.06 | 52 Week High | $22.01 | |||
| Open | $18.07 | 52 Week Low | $7.01 | |||
| Day High | $18.15 | P/E | N/A | |||
| Day Low | $16.96 | EPS | $0.00 | |||
| Volume | 4,849,572 | |||||

